In addition, patients with glioma experience elevated levels of an inhibitory cytokine, IL-10, which inhibits the expression of pro-inflammatory factors, mediates the function of Tregs, and inhibits the CD8+ T-cell-mediated cytotoxicity and antigen presentation of antigen-presenting cells [19]. Here, IL10 is linked to central nervous system cancer.